Match each clinical presentation with the most appropriate, guideline-directed primary antimicrobial therapy.
- A 24-year-old pregnant woman in her first trimester presents with an expanding erythematous targetoid rash and mild fatigue after a recent camping trip.Oral amoxicillin
- A 65-year-old man develops profuse, foul-smelling watery diarrhea and marked leukocytosis two weeks after completing treatment for community-acquired pneumonia.Oral fidaxomicin
- A 30-year-old man presents with a solitary, painless, indurated penile ulcer and bilateral inguinal lymphadenopathy; non-treponemal serology is reactive.Intramuscular penicillin G benzathine
- A 45-year-old woman with a history of injection drug use presents with high fever, a new holosystolic murmur, and blood cultures yielding methicillin-susceptible Staphylococcus aureus.Intravenous cefazolin
- A 19-year-old college student presents with sudden-onset fever, headache, nuchal rigidity, and a rapidly spreading petechial rash; cerebrospinal fluid analysis reveals Gram-negative diplococci.Intravenous ceftriaxone
Answer
Lyme disease in pregnancy matches with oral amoxicillin; Clostridioides difficile infection matches with oral fidaxomicin; primary syphilis matches with intramuscular penicillin G benzathine; MSSA endocarditis matches with intravenous cefazolin; meningococcal meningitis matches with intravenous ceftriaxone.
Each patient presentation maps to a specific, guideline-directed antimicrobial agent. Amoxicillin is safe for Lyme disease in pregnancy. Fidaxomicin is the preferred initial treatment for C. difficile. Penicillin G benzathine is the definitive therapy for primary syphilis. Cefazolin is superior for MSSA endocarditis. Ceftriaxone provides necessary CNS penetration for meningococcal meningitis.
Step-by-Step Solution
Key Concept
Targeted antimicrobial selection based on pathogen profile, site of infection, and host factors.